Oxytocin in Schizophrenia: a Review of Evidence for Its Therapeutic Effects

Overview

Journal Acta Neuropsychiatr

Publisher Cambridge University Press

Date 2012 Jun 28

PMID 22736892

Citations 37

Authors

Kai MacDonald

David Feifel

Affiliations

Soon will be listed here.

Abstract

Background: The suggestion that the neurohormone oxytocin may have clinical application in the treatment of schizophrenia was first published in 1972. Since then, a considerable body of research on a variety of fronts--including several recent double-blind treatment trials-has buttressed these early reports, providing support for the assertion that the oxytocin system is a promising and novel therapeutic target for this devastating malady. Herein, we review the diverse, convergent lines of evidence supporting the therapeutic potential of oxytocin in psychotic illness.

Methods: We performed a systematic review of preclinical and clinical literature pertaining to oxytocin's role in schizophrenia.

Results: Multiple lines of evidence converge to support the antipsychotic potential of oxytocin. These include several animal models of schizophrenia, pharmacological studies examining the impact of antipsychotics on the oxytocin system, human trials in patients examining aspects of the oxytocin system, and several double-blind, placebo-controlled clinical treatment trials.

Conclusions: There exists considerable, convergent evidence that oxytocin has potential as a novel antipsychotic with a unique mechanism of action. Auspiciously, based on the few chronic trials to date, its safety profile and tolerability appear very good. That said, several critical clinical questions await investigation before widespread use is clinically warranted.

Citing Articles

Contrasting Effects of Oxytocin on MK801-Induced Social and Non-Social Behavior Impairment and Hyperactivity in a Genetic Rat Model of Schizophrenia-Linked Features.

Sampedro-Viana D, Canete T, Ancil-Gascon P, Cisci S, Tobena A, Fernandez-Teruel A Brain Sci. 2024; 14(9).

PMID: 39335415 PMC: 11430565. DOI: 10.3390/brainsci14090920.

Evidence-based integration of yoga in psychiatric practice.

Gangadhar B Indian J Psychiatry. 2023; 65(1):5-11.

PMID: 36874516 PMC: 9983454. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_813_22.

Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis.

Hazani R, Lavidor M, Weller A Schizophr Bull. 2022; 48(6):1179-1193.

PMID: 35925025 PMC: 9673263. DOI: 10.1093/schbul/sbac093.

Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.

Goh K, Chen C, Wu T, Chen C, Lu M Int J Mol Sci. 2022; 23(13).

PMID: 35806096 PMC: 9266532. DOI: 10.3390/ijms23137092.

Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances.

Melis M, Argiolas A Int J Mol Sci. 2021; 22(19).

PMID: 34638719 PMC: 8509000. DOI: 10.3390/ijms221910376.

References

Braff D, Geyer M, Swerdlow N . Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001; 156(2-3):234-58. DOI: 10.1007/s002130100810. View

Legros J, Gazzotti C, Carvelli T, Franchimont P, Timsit-Berthier M, von Frenckell R . Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics. Psychoneuroendocrinology. 1992; 17(6):611-7. DOI: 10.1016/0306-4530(92)90019-4. View

Huber D, Veinante P, Stoop R . Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science. 2005; 308(5719):245-8. DOI: 10.1126/science.1105636. View

Rossoni E, Feng J, Tirozzi B, Brown D, Leng G, Moos F . Emergent synchronous bursting of oxytocin neuronal network. PLoS Comput Biol. 2008; 4(7):e1000123. PMC: 2440533. DOI: 10.1371/journal.pcbi.1000123. View

Bartz J, Zaki J, Bolger N, Ochsner K . Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci. 2011; 15(7):301-9. DOI: 10.1016/j.tics.2011.05.002. View

Ninan I . Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J Neurochem. 2011; 119(2):324-31. DOI: 10.1111/j.1471-4159.2011.07430.x. View

Light K, Smith T, Johns J, Brownley K, Hofheimer J, Amico J . Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity. Health Psychol. 2000; 19(6):560-7. DOI: 10.1037//0278-6133.19.6.560. View

Thompson R, Parker K, Hallmayer J, Waugh C, Gotlib I . Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology. 2010; 36(1):144-7. PMC: 2997902. DOI: 10.1016/j.psyneuen.2010.07.003. View

Carlsson A . Does dopamine play a role in schizophrenia?. Psychol Med. 1977; 7(4):583-97. DOI: 10.1017/s003329170000622x. View

10.

Wagenaar D, Hamilton M, Huang T, Kristan W, French K . A hormone-activated central pattern generator for courtship. Curr Biol. 2010; 20(6):487-95. PMC: 2858972. DOI: 10.1016/j.cub.2010.02.027. View

11.

Insel T . The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron. 2010; 65(6):768-79. PMC: 2847497. DOI: 10.1016/j.neuron.2010.03.005. View

12.

Meyer-Lindenberg A . From maps to mechanisms through neuroimaging of schizophrenia. Nature. 2010; 468(7321):194-202. DOI: 10.1038/nature09569. View

13.

Petrovic P, Kalisch R, Singer T, Dolan R . Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci. 2008; 28(26):6607-15. PMC: 2647078. DOI: 10.1523/JNEUROSCI.4572-07.2008. View

14.

Carter C . Developmental consequences of oxytocin. Physiol Behav. 2003; 79(3):383-97. DOI: 10.1016/s0031-9384(03)00151-3. View

15.

Tandon R, Keshavan M, Nasrallah H . Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 2008; 102(1-3):1-18. DOI: 10.1016/j.schres.2008.04.011. View

16.

Madden J, Clutton-Brock T . Experimental peripheral administration of oxytocin elevates a suite of cooperative behaviours in a wild social mammal. Proc Biol Sci. 2010; 278(1709):1189-94. PMC: 3049071. DOI: 10.1098/rspb.2010.1675. View

17.

Emiliano A, Cruz T, Pannoni V, Fudge J . The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects?. Neuropsychopharmacology. 2006; 32(5):977-88. DOI: 10.1038/sj.npp.1301206. View

18.

Adolphs R . How do we know the minds of others? Domain-specificity, simulation, and enactive social cognition. Brain Res. 2006; 1079(1):25-35. DOI: 10.1016/j.brainres.2005.12.127. View

19.

Carter C, Grippo A, Pournajafi-Nazarloo H, Ruscio M, Porges S . Oxytocin, vasopressin and sociality. Prog Brain Res. 2008; 170:331-6. DOI: 10.1016/S0079-6123(08)00427-5. View

20.

Ceanga M, Spataru A, Zagrean A . Oxytocin is neuroprotective against oxygen-glucose deprivation and reoxygenation in immature hippocampal cultures. Neurosci Lett. 2010; 477(1):15-8. DOI: 10.1016/j.neulet.2010.04.024. View